PET/CT Imaging in Oncology: Clinical Updates and Perspectives
This reprint focuses on the most recent advances in PET/CT imaging within the field of oncology. These innovations include studies on novel or experimental tracers, such as [18F]FES for the imaging of advanced breast cancer and [68Ga]Ga-Nitroimidazole for visualizing hypoxic tumour components; resea...
Збережено в:
| Формат: | Online |
|---|---|
| Мова: | Англійська |
| Опубліковано: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Предмети: | |
| Онлайн доступ: | ONIX_20231130_9783036594507_261 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| _version_ | 1869526206336991232 |
|---|---|
| collection | Directory of Open Access Books |
| description | This reprint focuses on the most recent advances in PET/CT imaging within the field of oncology. These innovations include studies on novel or experimental tracers, such as [18F]FES for the imaging of advanced breast cancer and [68Ga]Ga-Nitroimidazole for visualizing hypoxic tumour components; research on new radiopharmaceuticals represents, in fact, one the most important study fields of PET research. Advanced image analysis, such as radiomics, is also featured in this reprint; this method has been applied to both traditional nuclear medicine clinical issues, such as thyroid nodules, as well as in the setting of new therapeutic approaches, such as CAR-T cell therapy. Finally, the theranostic implications of PET radiotracers and the diagnostic processes of rare tumours are explored in this reprint. |
| format | Online |
| id | doab-20.500.12854ir-128809 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1288092024-03-31T13:09:45Z PET/CT Imaging in Oncology: Clinical Updates and Perspectives Piccardo, Arnoldo Fiz, Francesco thyroid incidentalomas radiomics texture analysis 18F-FDG PET/CT positron emission tomography thyroid cancer cervical cancer hypoxia 68Ga-Nitroimidazole HIF-1α immunohistochemistry Mantle Cell Lymphoma MTV TLG sarcopenia diffuse-large B cell lymphoma chimeric antigen receptor T cells response assessment computed tomography paraneoplastic syndromes neurooncology [18F]FDG PET/CT PNS FDG FES breast cancer oestrogen receptor diagnosis nuclear medicine meningioma peptide receptor radionuclide therapy PRRT targeted therapy somatostatin receptor SSTR n/a solitary fibrous tumor hemangiopericytoma fluorodeoxyglucose fluorocholine non-FDG radiopharmaceuticals [18F]FDG PET/MRI multiparametric imaging dual-time-point kinetic cervical carcinoma lymph node metastases PSMA hybrid imaging staging of primary prostate cancer [18F]PSMA-1007 [68Ga]Ga-PSMA-11 SUVmax cut-off level prostate carcinoma intra-tumoural heterogeneity intrahepatic cholangiocarcinoma positron emission tomography–computed tomography immunology FGFR2 translocation imaging fusion navigation technology immunotherapy Hodgkin lymphoma FDG-PET pseudoprogression LYRIC whole-body dynamic PET parametric FDG Patlak thema EDItEUR::M Medicine and Nursing This reprint focuses on the most recent advances in PET/CT imaging within the field of oncology. These innovations include studies on novel or experimental tracers, such as [18F]FES for the imaging of advanced breast cancer and [68Ga]Ga-Nitroimidazole for visualizing hypoxic tumour components; research on new radiopharmaceuticals represents, in fact, one the most important study fields of PET research. Advanced image analysis, such as radiomics, is also featured in this reprint; this method has been applied to both traditional nuclear medicine clinical issues, such as thyroid nodules, as well as in the setting of new therapeutic approaches, such as CAR-T cell therapy. Finally, the theranostic implications of PET radiotracers and the diagnostic processes of rare tumours are explored in this reprint. 2023-11-30T20:54:50Z 2023-11-30T20:54:50Z 2023 book ONIX_20231130_9783036594507_261 9783036594507 9783036594514 https://directory.doabooks.org/handle/20.500.12854/128809 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/8276 https://mdpi.com/books/pdfview/book/8276 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9451-4 10.3390/books978-3-0365-9451-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036594507 9783036594514 180 Basel open access |
| spellingShingle | thyroid incidentalomas radiomics texture analysis 18F-FDG PET/CT positron emission tomography thyroid cancer cervical cancer hypoxia 68Ga-Nitroimidazole HIF-1α immunohistochemistry Mantle Cell Lymphoma MTV TLG sarcopenia diffuse-large B cell lymphoma chimeric antigen receptor T cells response assessment computed tomography paraneoplastic syndromes neurooncology [18F]FDG PET/CT PNS FDG FES breast cancer oestrogen receptor diagnosis nuclear medicine meningioma peptide receptor radionuclide therapy PRRT targeted therapy somatostatin receptor SSTR n/a solitary fibrous tumor hemangiopericytoma fluorodeoxyglucose fluorocholine non-FDG radiopharmaceuticals [18F]FDG PET/MRI multiparametric imaging dual-time-point kinetic cervical carcinoma lymph node metastases PSMA hybrid imaging staging of primary prostate cancer [18F]PSMA-1007 [68Ga]Ga-PSMA-11 SUVmax cut-off level prostate carcinoma intra-tumoural heterogeneity intrahepatic cholangiocarcinoma positron emission tomography–computed tomography immunology FGFR2 translocation imaging fusion navigation technology immunotherapy Hodgkin lymphoma FDG-PET pseudoprogression LYRIC whole-body dynamic PET parametric FDG Patlak thema EDItEUR::M Medicine and Nursing PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title | PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title_full | PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title_fullStr | PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title_full_unstemmed | PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title_short | PET/CT Imaging in Oncology: Clinical Updates and Perspectives |
| title_sort | pet ct imaging in oncology clinical updates and perspectives |
| topic | thyroid incidentalomas radiomics texture analysis 18F-FDG PET/CT positron emission tomography thyroid cancer cervical cancer hypoxia 68Ga-Nitroimidazole HIF-1α immunohistochemistry Mantle Cell Lymphoma MTV TLG sarcopenia diffuse-large B cell lymphoma chimeric antigen receptor T cells response assessment computed tomography paraneoplastic syndromes neurooncology [18F]FDG PET/CT PNS FDG FES breast cancer oestrogen receptor diagnosis nuclear medicine meningioma peptide receptor radionuclide therapy PRRT targeted therapy somatostatin receptor SSTR n/a solitary fibrous tumor hemangiopericytoma fluorodeoxyglucose fluorocholine non-FDG radiopharmaceuticals [18F]FDG PET/MRI multiparametric imaging dual-time-point kinetic cervical carcinoma lymph node metastases PSMA hybrid imaging staging of primary prostate cancer [18F]PSMA-1007 [68Ga]Ga-PSMA-11 SUVmax cut-off level prostate carcinoma intra-tumoural heterogeneity intrahepatic cholangiocarcinoma positron emission tomography–computed tomography immunology FGFR2 translocation imaging fusion navigation technology immunotherapy Hodgkin lymphoma FDG-PET pseudoprogression LYRIC whole-body dynamic PET parametric FDG Patlak thema EDItEUR::M Medicine and Nursing |
| topic_facet | thyroid incidentalomas radiomics texture analysis 18F-FDG PET/CT positron emission tomography thyroid cancer cervical cancer hypoxia 68Ga-Nitroimidazole HIF-1α immunohistochemistry Mantle Cell Lymphoma MTV TLG sarcopenia diffuse-large B cell lymphoma chimeric antigen receptor T cells response assessment computed tomography paraneoplastic syndromes neurooncology [18F]FDG PET/CT PNS FDG FES breast cancer oestrogen receptor diagnosis nuclear medicine meningioma peptide receptor radionuclide therapy PRRT targeted therapy somatostatin receptor SSTR n/a solitary fibrous tumor hemangiopericytoma fluorodeoxyglucose fluorocholine non-FDG radiopharmaceuticals [18F]FDG PET/MRI multiparametric imaging dual-time-point kinetic cervical carcinoma lymph node metastases PSMA hybrid imaging staging of primary prostate cancer [18F]PSMA-1007 [68Ga]Ga-PSMA-11 SUVmax cut-off level prostate carcinoma intra-tumoural heterogeneity intrahepatic cholangiocarcinoma positron emission tomography–computed tomography immunology FGFR2 translocation imaging fusion navigation technology immunotherapy Hodgkin lymphoma FDG-PET pseudoprogression LYRIC whole-body dynamic PET parametric FDG Patlak thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20231130_9783036594507_261 |